an overall trendgold
7b ), there is an overall trend of elevated hepatic medium chain acylcarnitines and significantly decreased β-hydroxybutyrate (Supplementary Fig. 7c , Fig. 5f ), suggesting that hepatic MAT1A deficiency is associated with reduced hepatic fatty acid oxidation.